Browsing eNauka

Browsing by Author Rubin, David T

Showing results 1 to 5 of 5
Issue DateTitleAuthor(s)TypeМ-cat.
2022A Prospective Trial with Long Term Follow-up of Patients With Severe, Steroid-Resistant Ulcerative Colitis Who Received Induction Therapy With Cyclosporine and Were Maintained With VedolizumabTarabar, Dino K; El, Jurdi Katia; Traboulsi, Cindy; Yvellez, Olivia; Milenkovic, Zoran; Petrovic, Stanko S; Subotic, Bojana N; Gils, Ann; Brocic, Tanja P; Brcerevic, Irina A;
Latinovic, Olgica; Jocic, Tanja; Rubin, David T;
Article
21M21
2018Combination therapy of cyclosporine and vedolizumab is effective and safe for severe, steroid-resistant ulcerative colitis patients: A prospective studyTarabar, Dino K; El, Jurdi Katia; Yvellez, Olivia; Milenkovic, Zoran; Petrovic, Stanko S; Subotic, Bojana N; Brocic, Tanja P; Brcerevic, Irina A; Latinovic, Olgica; Rubin, David TConference Paper
Mp. category will be shown later
2014Crohn's Disease Behavior as a Risk Factor for Loss of Maintenance of Remission in Patients Treated With Certolizumab Pegol: Results From the PRECiSE 3 StudyRubin, David T; Randall, Charles; Coarse, Jason; Kosutic, Gordana; Spearman, Marshall; Ambarkhane, Sumeet; Jojic, Njegica ZConference Paper
Mp. category will be shown later
2022Long-term use of ozanimod in patients with moderately to severely active Ulcerative ColitisDanese, Silvio; Colombel, J-F; Ponich, T; Jovanovic, Igor; Bossuyt, Peter; Longman, R; Alekseeva, O; Petersen, AK; Chitkara, Denesh; Marta, C;
Charles, Lorna; Rubin, David T; Afzali, A; Loftus, EV Jr; Wolf, DC;
Conference Paper
Mp. category will be shown later
2016Vedolizumab in the treatment of Crohn's diseaseTarabar, Dino K; Hirsch, Ayal; Rubin, David TArticle
22M22